More Press Releases

View Older Stories View Newer Stories

Oct 19, 2025 03:00AM Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced
Oct 19, 2025 02:30AM DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom
Oct 19, 2025 02:30AM Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer
Oct 19, 2025 02:30AM Trodelvy® Reduces Risk of Disease Progression or Death by 38% Versus Chemotherapy as First-Line Therapy in Patients With Metastatic Triple-Negative Breast Cancer in ASCENT-03 Study
Oct 19, 2025 02:00AM Wialon Announces Top 10 GPS Hardware Manufacturers for 2025
Oct 19, 2025 02:00AM Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia
Oct 19, 2025 02:00AM Arbrest Champions Sustainability with Solid Wood Furniture That Extends the Life of Trees
Oct 19, 2025 12:39AM From Presentation to Full-Service Reception: AiMOGA Robot Demonstrates "Human Assistant" Capabilities at the 2025 Chery Global Innovation Conference
Oct 18, 2025 11:52PM Guardians of Continuity The Key to Alpha Wealth's Lasting Prosperity
Oct 18, 2025 11:47PM Divy Fashion Mart Introduces Investment Shopping for the Future
Oct 18, 2025 11:12PM How Avast Helps Protect Millions From Online Scams, Malware, and Phishing in 2025 - Report by Expert Consumers
Oct 18, 2025 10:51PM Metamorphosis Collective Announces Revolutionary 12 Week Program for High Achieving Women
Oct 18, 2025 10:47PM The Underfront Co. Announces Wilmington's New Cocktail Destination
Oct 18, 2025 10:45PM AdSolve Media Named Best Digital Marketing Agency in Edmonton
Oct 18, 2025 10:00PM From Galloping Messengers to One-Click Delivery: The Lychee Journey from Chang'an to Today.
Oct 18, 2025 09:00PM Harrah's Northern California Presents: Merry Millions - Win Up to $1 Million In Cash!
Oct 18, 2025 07:50PM Springfield Energy Founder Kevin Okyere Calls for Shared Action as 12% of Ghanaians Face Food Insecurity
Oct 18, 2025 07:05PM Pinnacle Funding Network Expands National DSCR Platform as Rates Hit Two-Year Low
Oct 18, 2025 04:45PM Local Chattanooga Author Stephanie Pleasant Releases Powerful Memoir "Vestiges of Light"
Oct 18, 2025 04:15PM Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results
Oct 18, 2025 04:13PM Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary Endpoint
Oct 18, 2025 03:00PM Crypto News (Live): From $0.0075 to $0.50? Blazpay’s AI Presale Heats Up as Solana and BNB Investors Seek New Gains
Oct 18, 2025 02:30PM Aurion Biotech Achieves All Primary, Secondary, and Exploratory Endpoints in AURN001 Phase 1/2 CLARA Trial at 12 Months
Oct 18, 2025 01:45PM Importance of Management Review Reports for ISO 27001 Certification
Oct 18, 2025 01:45PM New to The Street Show #694 to Broadcast Tonight at 6:30 PM EST as Sponsored Programming on Bloomberg TV Featuring Stardust Power (NASDAQ:SDST), Spartan Equipment, Roadzen (NASDAQ:RDZN), Aeries Techno
Oct 18, 2025 01:30PM Get Me to Costa Rica! Offers Life-Changing Travel Experience
Oct 18, 2025 01:27PM Dr. Beran Parry and the Advanced Bio Solutions Group Become Global Natural Medicine Leaders!
Oct 18, 2025 01:27PM HKUST Holds Congregation 2025 Conferring Honorary Doctorates on Five Distinguished Leaders
Oct 18, 2025 01:20PM Unlock SEO Success with the New Search Atlas Wordpress Plugin
Oct 18, 2025 01:51PM COME Mining Unleashes the Next Generation of Cloud Mining -- Powering BTC Machines with XRP and Earning Daily Rewards
Oct 18, 2025 01:47PM Joshua Washington's Lee Malveaux Rolls Out S.O.K.R.A.H. Framework for Enterprise Teams
Oct 18, 2025 12:39PM Raconteuse Skincare Unveils Sustainable Rituals That Blend Nature, Science, and Storytelling
Oct 18, 2025 01:31PM Modern Renovation Trends Transforming Ottawa Homes in 2025
Oct 18, 2025 12:34PM Sify Technologies to announce Financial Results for Second Quarter FY 2025-26 on Saturday, October 25, 2025
Oct 18, 2025 01:20PM Slangate Pioneering Financial Fraud Recovery with Technology and Global Expertise
Oct 18, 2025 12:10PM 13th Annual Energy Day Festival Sparks STEM Interest Among Houston Students
Oct 18, 2025 12:00PM Cupshe Unveils their For the Plot Party Collection in Collaboration with The Secret Lives of Mormon Wives Stars Jennifer Affleck, Demi Engemann, and Layla Taylor
Oct 18, 2025 11:43AM Trivolve Tech and Quixy Launch Forensic Management System (FMS) on Cardano Mainnet
Oct 18, 2025 11:31AM Liangzhu, where time speaks: Expats explore roots of Chinese civilization
Oct 18, 2025 11:29AM Michael Green, Chief Strategist at Simplify Asset Management, joins WealthVest: The Weekly Bull & Bear Podcast
Oct 18, 2025 11:15AM Crosby Brownlie Expands its Syracuse Location to Support Regional Growth
Oct 18, 2025 11:06AM The 6th International Ancient Capitals Forum Kicks off in Luoyang, Focusing on the Sustainable Development of Ancient Capitals
Oct 15, 2025 09:56AM /C O R R E C T I O N -- Express Wash Concepts/
Oct 18, 2025 11:00AM Maple Financial Announces Strategic Equity Investment from Nesto Group via CMLS
Oct 18, 2025 10:54AM Darkness to Light Expands National Scholarship Program Empowering Child Protection Leaders
Oct 18, 2025 10:42AM Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO
Oct 18, 2025 10:35AM KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Disease Progression or Death Versus Chemotherapy With or Without Bevacizumab in Certain Patients With Platinum-
Oct 18, 2025 10:35AM ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease recurrence or death by 53% vs. T-DM1 in patients with high-risk HER2-positive early breast cancer following neoadjuvant therapy
Oct 18, 2025 10:26AM Medome Launches New Medical Industry: Personal Health Intelligence TM - AI-Powered Personal Health Records to Usher In New Era of DIY Healthcare for ALL Americans
Oct 18, 2025 10:30AM KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 60% and Risk of Death by 50% for Certain Patients with Muscle-Invasive Bladder Cancer W
View Newer Stories View Older Stories